EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Azilsartan Attenuates Cognitive Dysfunction in a Rat Model of Cisplatin-Induced Neurotoxicity: Effects on Hematological and CBC-Derived Inflammatory Indices

Renas Ramadhan Ali, Naza Mohammed Ali Mahmood

Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) · 07.11.2026 · 11 (2) · 276-284

DOI: 10.54133/ajms.v11i2.3353 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), online erschienen am 07.11.2026. Verfasst von Renas Ramadhan Ali und 1 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cisplatin (CIS) is one of the common anticancer agents; nevertheless, its utility is often associated with cognitive dysfunction as well as systemic toxicities. Current therapeutic options remain inadequate in its prevention or management.

Objective

To investigate the effect of AZIL to mitigate CIS-induced neurotoxicity and associated systemic alterations in rats.

Methods

Thirty-nine female rats were initially enrolled and divided into 4 groups: I: Normal control group (NC), II: Cisplatin group (CIS), III: azilsartan group (AZIL), and IV: CIS and AZIL combination group (CIS+AZIL). Neurotoxicity was induced using 2.5mg/kg CIS twice weekly for 4 weeks. Body weight was measured weekly. Cognitive performance was assessed via the Y-maze test at baseline and the end of the experiment. Blood was collected at the end of the study for hematology and inflammatory index assessments.

Results

Azilsartan mitigated CIS-induced neurotoxicity and enhanced cognitive function. By week 4 CIS markedly lowers body weight, which is not prevented by AZIL. In the combination group, AZIL significantly improved learning performance and spatial working memory (p=0.0009) at week 4 compared to the CIS group. Hematological alterations were minimal, while co-administration of AZIL showed non-significant effects in NLR and PNR (p>0.05).

Conclusions

Azilsartan mitigated CIS-induced neurotoxicity and improved cognitive performance and several hematological parameters, especially RBC and hemoglobin. Changes in CBC-derived inflammatory indices showed limited alterations.

Zitieren

APA

Ali, R. R., & Mahmood, N. M. A. (2026). Azilsartan Attenuates Cognitive Dysfunction in a Rat Model of Cisplatin-Induced Neurotoxicity: Effects on Hematological and CBC-Derived Inflammatory Indices. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ), 11(2), 276-284. https://doi.org/10.54133/ajms.v11i2.3353

Vancouver

Ali RR, Mahmood NMA. Azilsartan Attenuates Cognitive Dysfunction in a Rat Model of Cisplatin-Induced Neurotoxicity: Effects on Hematological and CBC-Derived Inflammatory Indices. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 2026;11(2):276-284. doi:10.54133/ajms.v11i2.3353

BibTeX
@article{Ali2026,
  author = {Ali, Renas Ramadhan and Mahmood, Naza Mohammed Ali},
  title = {Azilsartan Attenuates Cognitive Dysfunction in a Rat Model of Cisplatin-Induced Neurotoxicity: Effects on Hematological and CBC-Derived Inflammatory Indices},
  journal = {Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 )},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {276--284},
  doi = {10.54133/ajms.v11i2.3353}
}
Kostenlos starten →